Silk Road Medical Appoints William Hill as General Counsel
SUNNYVALE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk...
News
Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock
TUSTIN, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (the “company”), a dedicated biologics contract development...
SmileDirectClub to Report First Quarter 2021 Results on May 10, 2021
NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
SI-BONE To Report First Quarter 2021 Financial Results on May 3, 2021
SANTA CLARA, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving...
Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update
STOUGHTON, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host...
SeaSpine Commences Public Offering of Common Stock
CARLSBAD, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical...
TG Therapeutics to Host Investor & Analyst Event to Preview Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis
Webcast to be held tomorrow, April 16, 2021 at 8:30 AM ETNEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- TG...
MINUTES OF ANNUAL GENERAL MEETING 2021
On 15 April 2021 at 15:00 (CEST), the annual general meeting (the "General Meeting") of Allarity Therapeutics A/S, company registration...
IBA – ACQUISITION OF OWN
Immediate Release – April 15th, 2021 Louvain-la-Neuve, Belgium, April 15th, 2021 - In accordance with article 8:4 of the Royal...
NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Call
WOBURN, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its...
Infant Bacterial Therapeutics receives additional patent protection in China
Infant Bacterial Therapeutics AB (IBT) today announces that the Chinese patent office has issued a decision to grant approval of...
Nabriva Commences Exclusive Distribution of SIVEXTRO® (tedizolid phosphate) in the U.S.
- SIVEXTRO now available under Nabriva’s National Drug Code - 100% of SIVEXTRO’s net product sales to be recorded by...
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
Article describes GigaGen’s technology and approach for the production of a new class of drug, recombinant hyperimmunes, including its novel...
Modernizing Medicine Acquires TRAKnet to Accelerate Innovation in Podiatry
Acquisition brings in talent and technology to strengthen Modernizing Medicine’s market position and deliver further innovation to the podiatry community...
Angle PLC Announces First Large-Scale Pharma Services Contract Secured
Contract Worth Up to US$1.2 Million With Potential for Further Contracts From the Same Customer Parsortix System Being Utilised in...
Procedures for Participating in Implanet’s Combined General Meeting of May 5, 2021 at 2 pm CEST
A webinar will be held at 6 pm CEST on April 20, 2021 following the publication of Q1 2021 revenue ...
Tree of Knowledge Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order
TORONTO, ON / ACCESSWIRE / April 15, 2021 / Tree of Knowledge International Corp. (CSE:TOKI) ("TOKI" or the "Company") would...
Solesis Announces Investment from Altaris Capital Partners
Altaris and Michelin will partner to accelerate Solesis’ growth TELFORD, Pa.--(BUSINESS WIRE)--Solesis Inc. (“Solesis” or the “Company”), the healthcare subsidiary...
PartsSource President and CEO Philip Settimi Named to Top 50 Healthcare Technology CEO List
CLEVELAND--(BUSINESS WIRE)--In recognition of his exceptional leadership, organizational performance and healthcare innovation in the face of a global pandemic over...
Ciitizen Partners with STXBP1 Foundation to Accelerate Patient Outcomes
Ciitizen’s Real World Evidence platform will accelerate the understanding of STXBP1 Disorders to find treatments for this rare, severe condition...